Virtual DCAT Member Company Announcement Forum
Hear from companies making news at the Virtual DCAT Member Company Announcement Forum
Coming July 12, 2021, Exclusive Viewing for DCAT Member Companies
Stay in the know and get the latest developments from across the bio/pharmaceutical manufacturing value chain at the Virtual DCAT Member Company Announcement Forum.
CEOs and senior executives from DCAT member companies will be announcing key strategic company developments, including significant manufacturing expansions, mergers and acquisitions (M&A), and post-M&A activities as part of the Virtual DCAT Member Company Announcement Forum.
Pre-recorded video announcements from the selected companies* will be available to the DCAT membership from July 12, 2021 through July 31, 2021 via the DCAT member portal. Email communications and the DCAT Value Chain Insights e-newsletter will alert members of their availability.
Hear from these high-level executives from DCAT member companies (listed alphabetically):
| Company | Speaker |
| Aceto | Gilles Cottier, CEO |
| Ajinomoto Bio-Pharma Services | Dr. Mark Cassidy, CEO & President, Ajinomoto Bio-Pharma Services Europe |
| Asymchem | Elut Hsu, President & Senior Vice President, Business Development |
| Benuvia | Scott Watson, President |
| Boehringer Ingelheim | Dr. Christian Eckermann, Senior Vice President, Biopharma Austria |
| Carbogen Amcis | Mark Griffiths, Dishman Carbogen Amcis Group CEO |
| Catalent | Karen Flynn, President, Biologics & Chief Commercial Officer |
| Cytiva | Emmanuel Ligner, Danaher Group Executive & President and CEO, Cytiva |
| DSM Nutritional Products | Kelsey Achenbach, Global Segment Director, Pharma & Medical Nutrition |
| Evonik | Dr. Stefan Randl, Vice President, Research, Development & Innovation, Nutrition & Care, Health Care, Evonik |
| Frontida BioPharm | Eric Kinzle, Ph.D., Study Director |
| Gerresheimer | Niels Düring, Global Executive Vice President, Primary Packaging Plastics |
| Helsinn Advanced Synthesis | Waldo Mossi, General Manager |
| LGM Pharma | Prasad Raje, CEO |
| Lonza | Christian Dowdeswell, Head of Commercial Development, Small Molecules |
| Ortec | Christopher Brotherton, President |
| PharmaBlock | Jing Li, Ph.D., Senior Vice President |
| Polpharma | Shlomo Gang, General Director, Polpharma API |
| Rondo-Pak | Bob Reilley, President & COO |
| Samsung Biologics | Segang Park, Vice President, Team Leader, Engineering Project Management, EPCV |
| Sanofi US SAIS/EuroAPI | Karl Rotthier, CEO, EuroAPI |
| Sterling Pharma Solutions | Kevin Cook, CEO |
| Stevanato Group | Mauro Stocchi, Chief Business Officer |
| Thermo Fisher Scientific | Leon Wyszkowski, President, Commercial Operations, Pharma Services |
| Valsynthese | Mara Guzzetti, Ph.D., Senior Executive Vice President, Fine Chemicals |
| WuXI STA | Yu Lu, Vice President, Business Operations, & Jinling Chen, Senior Vice President, Drug Product Division |
* Participating companies submit applications describing news announcements, which must be on the following: (1) key corporate strategic developments made in 2021; (2) mergers and acquisitions (M&A), including post-M&A integration; or (3) significant manufacturing expansions, including updated timelines for completion and launch. Announcements made prior to January 2021 must include updated timelines in 2021 or beyond for manufacturing expansions or in the case of M&A announcements, updates of post-M&A integration. Applications are reviewed by the DCAT Oversight Task Force, composed of volunteers from DCAT member companies, and are selected for participation based on meeting content and presentation criteria.